SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-122923
Filing Date
2024-04-29
Accepted
2024-04-29 17:25:42
Documents
23
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d492136ddef14a.htm   iXBRL DEF 14A 621926
6 GRAPHIC g492136g00a02.jpg GRAPHIC 22797
7 GRAPHIC g492136g00a03.jpg GRAPHIC 27686
8 GRAPHIC g492136g01n89.jpg GRAPHIC 30188
9 GRAPHIC g492136g15g15.jpg GRAPHIC 408464
10 GRAPHIC g492136g16g16.jpg GRAPHIC 211445
11 GRAPHIC g492136g46g01.jpg GRAPHIC 125060
12 GRAPHIC g492136g46g02.jpg GRAPHIC 116308
13 GRAPHIC g492136g47g01.jpg GRAPHIC 119211
14 GRAPHIC g492136g47g02.jpg GRAPHIC 119300
  Complete submission text file 0001193125-24-122923.txt   4055435

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20231231.xsd EX-101.SCH 4941
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20231231_def.xml EX-101.DEF 3974
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20231231_lab.xml EX-101.LAB 6670
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20231231_pre.xml EX-101.PRE 4273
26 EXTRACTED XBRL INSTANCE DOCUMENT d492136ddef14a_htm.xml XML 196328
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 24892947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)